Leucovorin is now accepted for cerebral folate deficiency months after FDA Commissioner Marty Makary claimed the decades-old generic drug had promise for treating autism. The FDA’s evaluate was primarily based on printed literature and real-world proof.
The publish FDA Drug Approval Marks a First for a Illness — However It’s Not Autism appeared first on MedCity Information.
